Collins Stewart Maintains a 'Buy' on Intuitive Surgical (NASDAQ: ISRG); Task Force Recommends Against PSA Screening - See Limited Fallout

Collins Stewart maintains a 'Buy' on Intuitive Surgical (NASDAQ: ISRG) price target of $450.00.

Collins analyst says, "The US Preventative Task Force, an influential panel of experts that develops recommendations for primary care clinicians and health
systems, issued an updated draft statement which no longer recommends prostate-specific antigen (PSA)-based screening for prostate cancer. If the task force follows through with its recommendations and compliance of no PSA screening is adopted, it would reduce the diagnosis of early-stage prostate cancer and, eventually, prostatectomies. However, our initial analysis is that the impact on ISRG will not be overly significant, and we estimate potentially a 1% impact to EPS in a few years."

For more ratings news on Intuitive Surgical click here and for the rating history of Intuitive Surgical click here.

Shares of Intuitive Surgical closed at $364.45 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
• NetEase.com (NTES) PT Raised to $168 at Goldman Sachs
• Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold